Innovative device for chronic heart failure, improving patient health and reducing hospitalizations.
Selera Medical was founded with the mission to revolutionize the treatment of chronic heart failure through innovative medical devices. The company focuses on developing a one-time, minimally invasive device that leverages the body's natural fluid management system to alleviate fluid overload, a primary cause of heart failure symptoms and hospitalizations. By improving patient health and reducing the need for recurrent hospital visits, Selera Medical aims to enhance the quality of life for millions affected by heart failure globally.
Notable affiliates and investors in Selera Medical include leading figures in the medical and venture capital communities, although specific names are not publicly disclosed. The company has achieved significant milestones in clinical trials, demonstrating the efficacy and safety of its device. Selera Medical's impact is marked by its potential to transform heart failure treatment, offering a sustainable solution that addresses both patient well-being and healthcare system burdens.

Corveus Medical
corveusmedical.com

V-Flow Medical

Reprieve Cardiovascular
reprievecardio.com

Senseer Health
senseer.us

Corinnova
corinnova.com

Sequitur Health
sequiturhealth.com

Vixiar Medical
vixiar.com

ReliantHeart
reliantheart.com

ReThink Medical

4C Medical Technologies
4cmed.com

Innovative Health

Renata Medical
renatamedical.com

CoRISMA MCS Systems
corismacv.com

Early Bird Medical
earlybirdmed.com

Second Heart Assist
secondheartinc.com

Maxwell Biomedical

Supira Medical
supiramedical.com

CoraVie Medical
coraviemedical.com

Luminate Medical
luminatemed.com
S.E.A. Medical Systems
seamedical.com
Selera Medical's most recent funding round was for $500k (USD) in January 2024.
As of Jan 1, 2024, Selera Medical has disclosed funding of $500k (USD).